This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA282660; GEO: GSE68405 |
| Type | Umbrella project |
| Publications | Muthana SM et al., "ABO blood type correlates with survival on prostate cancer vaccine therapy.", Oncotarget, 2015 Oct 13;6(31):32244-56 |
| Submission | Registration date: 29-Apr-2015
National Cancer Institute |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 3 |
A Simple, Inexpensive Strategy for Predicting Potential Beneficial Clinical Responses on Prostate Cancer Vaccine Therapy encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Other | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA282664 | Homo sapiens | Determination of ABO blood type for prostate cancer patients (National Cancer Institute) | | PRJNA282665 | Homo sapiens | Development of a glycan microarray based method for ABO blood typing (National Cancer Institute) |
|